Skip to main content
. 2023 May 13;15(5):335. doi: 10.3390/toxins15050335

Table 2.

Characteristics of the patients at T0 in all participants, and according to normal or decreased p-ROM. p-values refer to t-test for continuous variables and to Chi-square or Fisher’s exact test for categorical variables.

All Normal
p-ROM
Decreased p-ROM p-Value
ELBOW n = 48 n = 30 n = 18
Age, mean (SD) 66.44 (10.92) 63.57 (10.08) 71.22 (10.83) 0.017
Male Sex, n (%) 32 (67%) 22 (73%) 10 (56%) 0.206
Ischemic lesion, n (%) 35 (73%) 23 (77%) 12 (67%) 0.450
Years since stroke, mean (SD) 7.41 (4.60) 6.68 (4.23) 8.63 (5.04) 0.158
Number of previous injections, mean (SD) 7.13 (5.76) 7.27 (5.94) 6.89 (5.61) 0.829
Under treatment for spasticity 14 (29%) 10 (33%) 4 (22%) 0.521
Under treatment for depression 14 (29%) 10 (33%) 4 (22%) 0.521
MAS at T0 2.17 (0.87) 1.70 (0.50) 2.94 (0.80) <0.001
Loss of p-ROM at T0 --- --- 28.89 (20.90) ---
Posture at T0 2.44 (0.54) 2.30 (0.53) 2.67 (0.49) 0.0216
Pain at T0 2.26 (2.72) 0.57 (1.36) 5.08 (1.96) <0.001
FINGERS n = 64 n = 50 n = 14
Age, mean (SD) 65.36 (11.16) 65.14 (10.56) 66.14 (13.52) 0.769
Male Sex, n (%) 40 (63%) 33 (66%) 7 (50%) 0.274
Ischemic lesion, n (%) 43 (67%) 32 (64%) 11 (79%) 0.305
Years since stroke, mean (SD) 6.75 (4.46) 6.69 (4.42) 6.98 (4.75) 0.832
Number of previous injections, mean (SD) 5.97 (5.76) 5.90 (5.61) 6.21 (6.48) 0.858
Under treatment for spasticity 16 (25%) 12 (24%) 4 (29%) 0.736
Under treatment for depression 21 (33%) 14 (28%) 7 (50%) 0.196
MAS at T0 2.77 (0.66) 2.54 (0.50) 3.57 (0.51) <0.001
Loss of p-ROM at T0 --- --- 3.57 (0.85) ---
Posture at T0 2.30 (0.52) 2.18 (0.48) 2.71 (0.47) 0.001
Pain at T0 2.61 (3.61) 0.98 (1.89) 8.43 (1.74) <0.001